SARS-CoV-2 Illumina GeNome Assembly Line (SIGNAL), a Snakemate workflow for rapid and bulk analysis of Illumina sequencing of SARS-CoV-2 genomes
2024

SIGNAL: A Workflow for Analyzing SARS-CoV-2 Genomes

Sample size: 55 publication Evidence: high

Author Information

Author(s): Nasir Jalees, M. G. DeGroote, Maguire Finlay, Smith Kendrick, Panousis Emily, Baker Sheridan, Aftanas Patryk, Raphenya Amogelang, Alcock Brian, Maan Hassaan, Knox Natalie, Banerjee Arinjay, Mossman Karen, Wang Bo, Simpson Jared, Kozak Robert, Mubareka Samira, McArthur Andrew

Primary Institution: McMaster University

Hypothesis

The SIGNAL workflow can efficiently process large volumes of SARS-CoV-2 sequencing data for rapid analysis.

Conclusion

SIGNAL is one of the fastest-performing tools for analyzing SARS-CoV-2 sequencing data while maintaining high accuracy.

Supporting Evidence

  • SIGNAL was responsible for ∼50% of Ontario’s and ∼20% of Canada’s genome sequences shared internationally on GISAID.
  • SIGNAL has been used as the standard Illumina workflow at the Public Health Agency of Canada.
  • SIGNAL demonstrated a 10-fold faster performance than the next fastest workflow.

Takeaway

SIGNAL is a computer program that helps scientists quickly analyze a lot of virus samples to understand how the virus changes and spreads.

Methodology

SIGNAL uses Snakemake to manage parallel tasks for processing sequencing data, generating outputs like consensus genomes and variant calls.

Limitations

SIGNAL is limited to Illumina paired short-read sequencing data and is specialized for SARS-CoV-2 assembly.

Digital Object Identifier (DOI)

10.1093/nargab/lqae176

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication